Literature DB >> 21356790

Methylated CpG Island Amplification and Microarray (MCAM) for High-Throughput Analysis of DNA Methylation.

Marcos R H Estécio1, Pearlly S Yan, Tim H-M Huang, Jean-Pierre J Issa.   

Abstract

INTRODUCTIONThis protocol describes the use of methylated CpG island amplification (MCA) in combination with a microarray platform to analyze genome-wide DNA methylation in a high-throughput fashion. In this approach, termed MCAM, methylated CpG islands are selectively targeted using oligonucleotide adaptors after two rounds of digestion with a combination of methylation-sensitive and methylation-insensitive nucleases. They are then amplified using PCR. The resulting amplicons, representing the methylated fraction of the genome, are labeled with fluorochromes. Subsequently, a comparative hybridization of reference and test samples (typically normal and tumor DNA specimens) is done on a microarray platform.

Entities:  

Year:  2008        PMID: 21356790     DOI: 10.1101/pdb.prot4974

Source DB:  PubMed          Journal:  CSH Protoc        ISSN: 1559-6095


  3 in total

1.  Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancer.

Authors:  Yoshichika Oishi; Yoshiyuki Watanabe; Yoshihito Yoshida; Yoshinori Sato; Tetsuya Hiraishi; Ritsuko Oikawa; Tadateru Maehata; Hiromu Suzuki; Minoru Toyota; Hirohumi Niwa; Michihiro Suzuki; Fumio Itoh
Journal:  Tumour Biol       Date:  2011-12-08

2.  The epigenome of AML stem and progenitor cells.

Authors:  Jumpei Yamazaki; Marcos R Estecio; Yue Lu; Hai Long; Gabriel G Malouf; David Graber; Yujia Huo; Louis Ramagli; Shoudan Liang; Steven M Kornblau; Jaroslav Jelinek; Jean-Pierre J Issa
Journal:  Epigenetics       Date:  2012-12-18       Impact factor: 4.528

3.  The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.

Authors:  Stephany Orjuela; Mirco Menigatti; Peter Schraml; Patryk Kambakamba; Mark D Robinson; Giancarlo Marra
Journal:  BMC Cancer       Date:  2020-04-06       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.